News

By Giovanna Verginelli Mezher

December 22, 2023

2024-2025 Regulatory Agenda Has Been Approved by the Brazilian FDA

ANVISA’s new Regulatory Agenda 2024-2025 (RA 24/25) was approved and published on the Official Gazette on December 18th. The Joint Ordinance No. 2024-2025 Regulatory Agenda Has Been Approved by the Brazilian FDA

Ler notícia

December 15, 2023

Increase in Patients Using Medicinal Cannabis and Its Consequences

The number of Brazilians using medicinal cannabis-based medications increased by approximately 165% in one year, representing a jump from 188,000 to 430,000 Increase in Patients Using Medicinal Cannabis and Its Consequences

Ler notícia

December 12, 2023

Anvisa approves skinny labeling practice in Brazil

Starting February 6, 2024, generic and branded-generic (“similar”) drugs will be allowed to have different labels than their respective standard labels with Anvisa approves skinny labeling practice in Brazil

Ler notícia

October 30, 2023

ANVISA’s Personal Data Protection Policy is released

On October 19, 2023, the Federal Official Gazette (DOU) published Administrative Order 1,184/2023, which provides for the National Health Surveillance Agency’s (Anvisa) ANVISA’s Personal Data Protection Policy is released

Ler notícia

October 11, 2023

Lexology GTDT – Pharma & Medical Device Regulation 2024

The chapter “Pharma & Medical Device Regulation,” authored by our partners Claudio Barbosa, Viviane Trojan and attorney at law Giovanna Mezher, has Lexology GTDT – Pharma & Medical Device Regulation 2024

Ler notícia

October 9, 2023

Green light from ANVISA regarding the registration of biosimilar medicines in Brazil

The National Health Surveillance Agency (ANVISA) has approved the opening of a Public Consultation to amend the regulation of biosimilar medicines in Brazil Green light from ANVISA regarding the registration of biosimilar medicines in Brazil

Ler notícia
plugins premium WordPress